## CLX: Clorox Company (The) - XLP: Consumer Defensive

### Executive Summary

No thesis match: MRS_10 0.3% below STRENGTH zone (3.0-6.0%); PEG 3.44 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.0% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($101.45)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 9
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Hsbc Holdings PLC Sells 70,825 Shares of The Clorox Company $CLX**
- Source: MarketBeat | 20251130T114626 | Neutral | Relevance: 99%
- Hsbc Holdings PLC reduced its stake in The Clorox Company by 6.5% during Q2 2025, selling 70,825 shares and retaining 1,014,836 shares valued at approximately $121.6 million. The article also details other institutional investor activity, insider transactions including purchases by Director Pierre R. Breber and sales by COO Eric H. Reynolds, and recent analyst ratings that have resulted in a consensus "Reduce" rating with an average price target of $125.69. Clorox reported quarterly earnings of $0.85 EPS, beating estimates, and declared a quarterly dividend of $1.24 per share.

**2. The Clorox Company $CLX Shares Sold by Skandinaviska Enskilda Banken AB publ**
- Source: MarketBeat | 20251201T115042 | Neutral | Relevance: 99%
- Skandinaviska Enskilda Banken AB publ decreased its stake in The Clorox Company (NYSE:CLX) by 30.3% in Q2, while other major institutions like Norges Bank, Hsbc Holdings PLC, and Nuance Investments LLC significantly increased their holdings. Clorox reported quarterly EPS of $0.85, exceeding estimates, but revenue declined by 18.9% year-over-year. The company declared a quarterly dividend of $1.24, and analysts maintain a "Reduce" consensus rating with a target price of $125.69.

**3. BLI Banque de Luxembourg Investments Sells 10,500 Shares of The Clorox Company $CLX**
- Source: MarketBeat | 20251130T083233 | Neutral | Relevance: 98%
- BLI Banque de Luxembourg Investments reduced its stake in The Clorox Company by 13.9% in the second quarter, selling 10,500 shares. Several other institutional investors also adjusted their positions in CLX, while director Pierre R. Breber purchased 4,000 shares and COO Eric H. Reynolds sold over 15,000 shares. The article also provides a financial overview of Clorox, its recent earnings, dividend announcement, and current analyst ratings.

**4. Franklin Resources Inc. Has $18.48 Million Stake in The Clorox Company $CLX**
- Source: MarketBeat | 20251130T091608 | Neutral | Relevance: 97%
- Franklin Resources Inc. reduced its stake in The Clorox Company by 27.7% in Q2, ending the period with 153,911 shares valued at $18.48 million. Clorox reported Q1 EPS of $0.85, beating estimates, and announced a quarterly dividend of $1.24 per share. Insider trading activity included a director acquiring shares and the COO selling a significant portion of his holdings.

**5. 5,909 Shares in The Clorox Company $CLX Bought by Employees Retirement System of Texas**
- Source: MarketBeat | 20251129T114506 | Neutral | Relevance: 97%
- The Employees Retirement System of Texas acquired 5,909 shares of The Clorox Company (NYSE:CLX) valued at approximately $709,000 during the second quarter, contributing to institutional ownership of nearly 78.53%. Clorox surpassed Q2 earnings expectations with $0.85 EPS and $1.43 billion revenue, though revenue was down 18.9% year-over-year. The company declared a quarterly dividend of $1.24 per share, while analysts maintain a "Reduce" consensus rating with an average target price of $125.69.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 21 ($20.47M) |
| Sells | 4 ($1.06M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 44.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 12.9% (-0.7%)
- Blackrock Inc.: 8.5% (-1.2%)
- State Street Corpora: 6.9% (+3.5%)
- Invesco Ltd.: 3.3% (+23.1%)
- Morgan Stanley: 2.6% (+18.3%)

### Key Risks

1. Valuation stretched: PEG 3.4x requires aggressive growth execution.
2. Long-term trend broken: trading 17.1% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 3.44 signals overvaluation risk, limited margin of safety. Quality metrics strong (ROE 44%, ROA 12%). Insider buying signal ($20.5M), management confidence. Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $12.5B |
| Beta | 0.57 |
| 52W Range | $98.20 - $169.15 |
| Short Interest | 6.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.44 |
| Forward P/E | 15.7 |
| Current P/E | 17.8 |
| YoY Growth | 12.9% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 2.4% to 0.3% (-2.0% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 2.7pp (needs >3.0% for momentum thesis). MRS_5 (-1.0%) diverging from MRS_10 - short-term weakness emerging. Below SMA200 (0.83x), long-term trend not supportive. MACD histogram positive (1.07), confirming momentum. RSI neutral at 46.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 0.31% (CS: 66) | Neutral |
| RSI_14 | 45.9 | Neutral |
| MACD Histogram | 1.07 | Bullish |
| vs SMA20 | 1.012x | Above |
| vs SMA50 | 0.937x | Below |
| vs SMA200 | 0.829x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $106.41
- **Stop Loss:** $101.45 (4.7% risk)
- **Target:** $111.37 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 241
- **Position Value:** $25,644.81
- **Portfolio %:** 25.64%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | TREND (Zone A) | 1.20x |

### Earnings

**Next:** 2026-02-03 (Est: $1.45)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.78 | $0.85 | +9.2% |
| 2025Q2 | $2.21 | $2.87 | +29.8% |
| 2025Q1 | $1.56 | $1.45 | -6.9% |
| 2024Q4 | $1.40 | $1.55 | +10.7% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_10*